FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tatsunobu Yoshioka

Research Profile

Chemicals & Drugs

Living Beings

Objects

Procedures

Anatomy

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
Yasuo Yoshioka; Ryo Suzuki; Hiroaki Oka; Naoki Okada; Takayuki Okamoto; Tatsunobu Yoshioka; Yohei Mukai; Hiroko Shibata; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Tadanori Mayumi
A novel cytomedical vehicle capable of protecting cells against complement.
Ryo Suzuki; Naoki Okada; Hajime Miyamoto; Tatsunobu Yoshioka; Kayoko Sakamoto; Hiroaki Oka; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Tadanori Mayumi
Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines.
Ryo Suzuki; Yasuo Yoshioka; Etsuko Kitano; Tatsunobu Yoshioka; Hiroaki Oka; Takayuki Okamoto; Naoki Okada; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Hajime Kitamura; Tadanori Mayumi
Development of a novel cytomedical treatment that can protect entrapped cells from host humoral immunity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tatsunobu Yoshioka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Yasuo Yoshioka; Ryo Suzuki; Hiroaki Oka; Naoki Okada; Takayuki Okamoto; Tatsunobu Yoshioka; Yohei Mukai; Hiroko Shibata; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Tadanori Mayumi
A novel cytomedical vehicle capable of protecting cells against complement.
Biochemical and biophysical research communications 2003;305(2):353-8.
2002: Ryo Suzuki; Naoki Okada; Hajime Miyamoto; Tatsunobu Yoshioka; Kayoko Sakamoto; Hiroaki Oka; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Tadanori Mayumi
Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines.
Life sciences 2002;71(15):1717-29.
2002: Ryo Suzuki; Yasuo Yoshioka; Etsuko Kitano; Tatsunobu Yoshioka; Hiroaki Oka; Takayuki Okamoto; Naoki Okada; Yasuo Tsutsumi; Shinsaku Nakagawa; Jun-ichi Miyazaki; Hajime Kitamura; Tadanori Mayumi
Development of a novel cytomedical treatment that can protect entrapped cells from host humoral immunity.
Cell transplantation 2002;11(8):787-97.
1999: Hajime Miyamoto; Naoki Okada; Tatsunobu Yoshioka; Ryo Suzuki; Kayoko Sakamoto; Asao Katsume; Hiroshi Saito; Yasuo Tsutsumi; K Kubo; Shinsaku Nakagawa; Yoshiyuki Ohsugi; Tadanori Mayumi
Prolongation of the effective duration of cytomedical therapy by re-injecting SK2 hybridoma cells microencapsulated within alginate-poly(L)lysine-alginate membranes into human interleukin-6 transgenic mice.
Biological & pharmaceutical bulletin 1999;22(3):295-7.
1998: H Yamamura; Yasushi Nakamori; Atsushi Hiraide; Tatsunobu Yoshioka; Hisashi Sugimoto
Surgical treatment for massive gastrointestinal bleeding caused by thrombotic thrombocytopenic purpura: a case report.
Surgery 1998;124(5):929-31.
1997: Tadahiko Shiozaki; Osamu Tasaki; M Ohnishi; T Nishimura; Atsushi Hiraide; Takeshi Shimazu; Tatsunobu Yoshioka; Hisashi Sugimoto
Paradoxical positive nitrogen balance in burn patients receiving high-dose administration of insulin for nutritional care.
Surgery 1997;122(3):527-33.
1997: Naoki Okada; Hajime Miyamoto; Tatsunobu Yoshioka; Asao Katsume; Hiroshi Saito; Keigo Yorozu; Otoya Ueda; Shinsaku Nakagawa; Yoshiyuki Ohsugi; Tadanori Mayumi
Therapeutic effect of cytomedicine on mesangio-proliferative glomerulonephritis in human interleukin-6 transgenic mice.
Biological & pharmaceutical bulletin 1997;20(3):255-8.
1997: Naoki Okada; Hajime Miyamoto; Tatsunobu Yoshioka; Asao Katsume; Hiroshi Saito; Keigo Yorozu; Otoya Ueda; Norio Itoh; Hiroyuki Mizuguchi; Shinsaku Nakagawa; Yoshiyuki Ohsugi; Tadanori Mayumi
Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane.
Biochimica et biophysica acta 1997;1360(1):53-63.
1997: Naoki Okada; Hajime Miyamoto; Tatsunobu Yoshioka; Kayoko Sakamoto; Asao Katsume; Hiroshi Saito; Shinsaku Nakagawa; Yoshiyuki Ohsugi; Tadanori Mayumi
Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation.
Biochemical and biophysical research communications 1997;230(3):524-7.